NASDAQ:NTLA | EBITDA | Intellia Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2015-12-31 to 2026-06-30
Data captured

Historical EBITDA

DateEBITDA
2026-06-30-$110.66M
2026-03-31-$98.33M
2025-12-31-$96.33M
2025-09-30-$109.08M
2025-06-30-$107.5M
2025-03-31-$118.31M
2024-12-31-$133.88M
2024-09-30-$142.17M
2024-06-30-$136.44M
2024-03-31-$111.49M
2023-12-31-$137.43M
2023-03-31-$109.91M
2022-12-31-$108.06M
2022-03-31-$142.49M
2021-12-31-$78.54M
2021-03-31-$44.83M
2020-12-31-$40.8M
2020-03-31-$31.51M
2019-12-31-$28.21M
2019-03-31-$22.51M
2018-12-31-$19.52M
2018-03-31-$21.42M
2017-12-31-$23.88M
2017-03-31-$12.29M
2016-12-31-$10.42M

Annual EBITDA

DateEBITDA
2025-12-31-$431.22M
2024-12-31-$523.98M
2023-12-31-$506.32M
2022-12-31-$450.59M
2021-12-31-$260.96M
2020-12-31-$130.27M
2019-12-31-$100.78M
2018-12-31-$86.41M
2017-12-31-$66.56M
2016-12-31-$31.06M
2015-12-31-$13.08M